Development of Bio Equivalency Studies in Armenia

12 June 2018 - 12 June 2025
  • Project Cost:
  • $ 4,600,000

The project is about the establishment of a complex which will enable to conduct bio equivalence studies for generic drugs.Drug producers need to get the evidence of compliance of generic drug to brand one. The only way to prove it is bio equivalence study results. Drug registration bodies in all countries require Dossiers, as an evidence that this generic drug is equivalent to brand one. It is impossible to register generics without Dossiers.Bio equivalence study will assure that new generic is safe, efficient and corresponds to quality requirements.The project implementation will involve:

  • Clinic for volunteers /for in vivo studies,
  • Analytical laboratory /for blood sample analyses,
  • R&D department /for project management, statistical analyses, report writing and Dossiers design.

If you have any questions - contact us!

Our company

Our company was founded in 2006. We are a creative and energy team with love for development technologies. With every new project we try to achieve perfection.